✦ LIBER ✦

Clinical and Parasite Species Risk Factors for Pentavalent Antimonial Treatment Failure in Cutaneous Leishmaniasis in Peru

✍ Scribed by Llanos-Cuentas, A.; Tulliano, G.; Araujo-Castillo, R.; Miranda-Verastegui, C.; Santamaria-Castrellon, G.; Ramirez, L.; Lazo, M.; De Doncker, S.; Boelaert, M.; Robays, J.; Dujardin, J.-C.; Arevalo, J.; Chappuis, F.

Book ID: 125887405
Publisher: University of Chicago Press
Year: 2008
Tongue: English
Weight: 360 KB
Volume: 46
Category: Article
ISSN: 1058-4838
DOI: 10.1086/524042

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk factors for clinical failure in pat

Risk factors for clinical failure in patients hospitalized with cellulitis and cutaneous abscess

✍ Jenana Halilovic; Brett H. Heintz; Jennifer Brown 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 176 KB

Comparison of miltefosine and meglumine

Comparison of miltefosine and meglumine antimoniate for the treatment of zoonotic cutaneous leishmaniasis (ZCL) by a randomized clinical trial in Iran

✍ M. Mohebali; A. Fotouhi; B. Hooshmand; Z. Zarei; B. Akhoundi; A. Rahnema; A.R. R 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Mucosal leishmaniasis: description of ca

Mucosal leishmaniasis: description of case management approaches and analysis of risk factors for treatment failure in a cohort of 140 patients in Brazil

✍ VS Amato; FF Tuon; R Imamura; R Abegão de Camargo; MI Duarte; VA Neto 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 578 KB

A clinical trial to evaluate the safety

A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1 + MPL-SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasis

✍ Evaldo Nascimento; Demetrios F. Fernandes; Edva P. Vieira; Antonio Campos-Neto; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 335 KB